Latest news on Laboratorytalk categorised by supplier
Ablynx
Address:
Technologiepark 4
Ghent
9052
Belgium
Our RSS feed for news from Ablynx
Request to receive our free email newsletter each week
Listing of all 3 news releases from Ablynx:
Agreement to develop new Alzheimer's treatments
Ablynx and Boehringer Ingelheim sign $265 million research and licensing agreement to develop new Alzheimer's treatments
News from Ablynx ( 9 January 2007)
Nanobodies reach milestone in P+G collaboration
Nanobody technology has been used to rapidly identify a highly diverse and potent panel of Nanobodies against one of the targets exclusive to the collaboration, triggering a milestone payment
News from Ablynx (14 December 2006)
Research and license agreement with Wyeth
Ablynx enters deal with Wyeth Pharmaceuticals to discover, develop and commercialise Nanobodies directed at the tumour necrosis factor alpha protein and its receptors
News from Ablynx (14 November 2006)

